Comfortage - AD Prevention Strategies

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age50-85
SponsorFondazione Policlinico Universitario Agostino Gemelli IRCCS

About this trial

Study is Interventional, cross-sectional, clinical trial without drug and without device

Eligibility criteria

Qualifiers

subjective cognitive decline, defined as self-experienced persistent decline in cognitive capacity in comparison with a previously normal status and unrelated to an acute event; normal performance on standardised cognitive tests adjusted for age, sex, and education; decline cannot be explained by psychiatric or other neurologic disease, medical disorder, medication, or substance use; no functional impact on daily life activities

mild cognitive decline, defined as persistent decline in cognitive performance (in comparison with a previous status) reported by the subject or by an informed caregiver; or observed by change on longitudinal cognitive testing; cognitive performance below expected range for that individual based on cognitive test performance (adjusted for age, sex, and education); performs daily life activities independently (but cognitive difficulty may result in detectable but minimal functional impact on the more complex activities of daily life, either self-reported or corroborated by a study partner); Clinical Dementia Rating Scale = 0.5

Ability to sign and understand the informed consent form

Disqualifiers

Age under 50 or over 85 years

Non-native Italian speakers

Non degenerative and secondary forms of dementia

Previous or current participation in clinical trials with anti-amyloid agents

Trial design

Treatments tested in this trial

  • Neuropsychological Assessments and Other Questionnaires
  • Blood Exams, Fluid Biomarkers, Genetics
  • Connectivity Analysis
  • Physical Activity
  • Healthentia
  • Eligence
  • Nutrition

Treatment groups

200 Participants
are divided into 1 treatment group

Locations

This trial has no locations